Search

everythinglearnresearchcommunity

for

Search:↓

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Diabetes often causes various skin problems and complications.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Treat adult facial vascular anomalies with lasers, surgery, or observation, depending on the patient's specific condition.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Botulinum toxin A effectively treated a man's facial cysts with no side effects and lasting results.